Central line-associated bloodstream infections in neonates
Korean Journal of Pediatrics · 15.03.2019 · 62 (3) · 79-84
DOI: 10.3345/kjp.2018.07003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Korean Journal of Pediatrics, erschienen am 15.03.2019. Verfasst von Hye Jung Cho und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Newborn infants, including premature infants, are high-risk patients susceptible to various microorganisms. Catheter-related bloodstream infections are the most common type of nosocomial infections in this population. Regular education and training of medical staffs are most important as a preventive strategy for central line-associated bloodstream infections (CLABSIs). Bundle approaches and the use of checklists during the insertion and maintenance of central catheters are effective measures to reduce the incidence of CLABSIs. Chlorhexidine, commonly used as a skin disinfectant before catheter insertion and dressing replacement, is not approved for infants
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
Zitieren
APA
Cho, H. J., & Cho, H. K. (2019). Central line-associated bloodstream infections in neonates. Korean Journal of Pediatrics, 62(3), 79-84. https://doi.org/10.3345/kjp.2018.07003
Vancouver
Cho HJ, Cho HK. Central line-associated bloodstream infections in neonates. Korean Journal of Pediatrics. 2019;62(3):79-84. doi:10.3345/kjp.2018.07003
BibTeX
@article{Cho2019,
author = {Cho, Hye Jung and Cho, Hye-Kyung},
title = {Central line-associated bloodstream infections in neonates},
journal = {Korean Journal of Pediatrics},
year = {2019},
volume = {62},
number = {3},
pages = {79--84},
doi = {10.3345/kjp.2018.07003}
}
EUVIMED